Ann Hepatobiliary Pancreat Surg.  2017 May;21(2):76-79. 10.14701/ahbps.2017.21.2.76.

Central pancreatectomy: an oncologically safe option to treat metastases of other neoplasms of the mid-portion of the pancreas?

• Dumitrascu T
• Scarlat A
• Ionescu M
• Popescu I

• KMID: 2379104
• DOI: http://doi.org/10.14701/ahbps.2017.21.2.76

Abstract

BACKGROUNDS/AIMS
Standard pancreatic resections are the current approach for patients with resectable, isolated pancreatic metastases of other neoplasms. However, the role of parenchyma-sparing pancreatectomies for such pathology is poorly investigated. The aim of the present study is to assess the oncological safety of central pancreatectomies for pancreatic metastases of other neoplasms.
METHODS
A literature search was performed in order to identify patients with central pancreatectomies for pancreatic metastases of other neoplasms. The available data of the patients were extracted and analyzed.
RESULTS
A total number of 16 patients were identified. Renal carcinoma was the primary origin for the largest number of these patients (11 patients - 69%). The mean overall survival time was 109 months, with 1-, 5- and 10-year survival rates of 100%, 84%, and 60%, respectively.
CONCLUSIONS
Although not often performed, a central pancreatectomy appears to be an oncologically safe surgical procedure in select patients with pancreatic metastases of other neoplasms of the pancreatic body and isthmus. However, no definitive conclusions should be drawn, based on the data provided in the present study, due to the limited number and heterogeneity of the patients.

Keyword

Central pancreatectomy; Pancreatic metastases; Survival

MeSH Terms

Humans
Neoplasm Metastasis*
Pancreas*
Pancreatectomy*
Pathology
Population Characteristics
Survival Rate

Figure

• 

  Fig. 1 The Kaplan-Meier overall survival curve in patients with central pancreatectomies for pancreatic metastases of other neoplasms.

Reference

1. Dumitrascu T, Popescu I. Central pancreatectomy revisited. J Transl Med Res. 2015; 20:185–194.

2. Iacono C, Verlato G, Ruzzenente A, Campagnaro T, Bacchelli C, Valdegamberi A, et al. Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. Br J Surg. 2013; 100:873–885.

3. Cataldegirmen G, Schneider CG, Bogoevski D, Koenig A, Kaifi JT, Bockhorn M, et al. Extended central pancreatic resection as an alternative for extended left or extended right resection for appropriate pancreatic neoplasms. Surgery. 2010; 147:331–338.

4. Dumitrascu T, Scarlat A, Ionescu M, Popescu I. Central pancreatectomy versus spleen-preserving distal pancreatectomy: a comparative analysis of early and late postoperative outcomes. Dig Surg. 2012; 29:400–407.

5. Dumitraşcu T, Barbu ST, Ionescu M, Popescu I. POSSUM, a potentially useful tool for prediction of morbidity in patients undergoing central pancreatectomy. Chirurgia (Bucur). 2012; 107:447–453.

6. Goudard Y, Gaujoux S, Dokmak S, Cros J, Couvelard A, Palazzo M, et al. Reappraisal of central pancreatectomy a 12-year single-center experience. JAMA Surg. 2014; 149:356–363.

7. Dumitrascu T, Barbu ST, Purnichescu-Purtan R, Ionescu M, Popescu I. Risk factors for surgical complications after central pancreatectomy. Hepatogastroenterology. 2012; 59:592–598.

8. Crippa S, Bassi C, Warshaw AL, Falconi M, Partelli S, Thayer SP, et al. Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg. 2007; 246:69–76.

9. de Clavière G, Paye F, Fteriche S, Terris B, Belghiti J, Sauvanet A. Medial pancreatectomy: results of a series of 11 patients. Ann Chir. 2002; 127:48–54.

10. Deguchi Y, Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, et al. Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: report of a case. Surg Today. 2009; 39:1086–1090.

11. Dumitrascu T, Scarlat A, Ciurea S, Popescu I. Central pancreatectomy for a pancreatic metastasis of colon cancer - a case report. J Transl Med Res. 2015; 20:153–156.

12. Dumitraşcu T, Dima S, Popescu C, Gheonea DI, Ciurea T, Saftoiu A, et al. An unusual indication for central pancreatectomy--late pancreatic metastasis of ocular malignant melanoma. Chirurgia (Bucur). 2008; 103:479–485.

13. Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, et al. A central pancreatectomy for benign or low-grade malignant neoplasms. J Gastrointest Surg. 2009; 13:1659–1665.

14. Müller MW, Friess H, Kleeff J, Hinz U, Wente MN, Paramythiotis D, et al. Middle segmental pancreatic resection: An option to treat benign pancreatic body lesions. Ann Surg. 2006; 244:909–918.

15. Sauvanet A, Partensky C, Sastre B, Gigot JF, Fagniez PL, Tuech JJ, et al. Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the French Pancreas Club. Surgery. 2002; 132:836–843.

16. Shikano T, Nakao A, Kodera Y, Yamada S, Fujii T, Sugimoto H, et al. Middle pancreatectomy: safety and long-term results. Surgery. 2010; 147:21–29.

17. Adler H, Redmond CE, Heneghan HM, Swan N, Maguire D, Traynor O, et al. Pancreatectomy for metastatic disease: a systematic review. Eur J Surg Oncol. 2014; 40:379–386.

18. Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009; 10:287–293.

19. Crippa S, Angelini C, Mussi C, Bonardi C, Romano F, Sartori P, et al. Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg. 2006; 30:1536–1542.

20. Strobel O, Hackert T, Hartwig W, Bergmann F, Hinz U, Wente MN, et al. Survival data justifies resection for pancreatic metastases. Ann Surg Oncol. 2009; 16:3340–3349.

21. Untch BR, Allen PJ. Pancreatic metastasectomy: the Memorial Sloan-Kettering experience and a review of the literature. J Surg Oncol. 2014; 109:28–30.

22. Konstantinidis IT, Dursun A, Zheng H, Wargo JA, Thayer SP, Fernandez-del Castillo C, et al. Metastatic tumors in the pancreas in the modern era. J Am Coll Surg. 2010; 211:749–753.

23. Kwak JH, Heo JS, Park JY, Choi DW, Choi SH, Lee HS. Outcomes of pancreaticoduodenectomy in patients with metastatic cancer. Korean J Hepatobiliary Pancreat Surg. 2014; 18:147–151.

24. Yazbek T, Gayet B. The place of enucleation and enucleo-resection in the treatment of pancreatic metastasis of renal cell carcinoma. JOP. 2012; 13:433–438.

25. Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol. 2008; 15:1161–1168.

26. Bassi C, Butturini G, Falconi M, Sargenti M, Mantovani W, Pederzoli P. High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg. 2003; 90:555–559.

27. Reddy S, Edil BH, Cameron JL, Pawlik TM, Herman JM, Gilson MM, et al. Pancreatic resection of isolated metastases from non-pancreatic primary cancers. Ann Surg Oncol. 2008; 15:3199–3206.

28. Psarakis HM. Clinical challenges in caring for patients with diabetes and cancer. Diabetes Spectr. 2006; 19:157–162.

29. Jeong Y, Han HS, Lee HD, Yang J, Jeong J, Choi MK, et al. A Pilot Study evaluating steroid-induced diabetes after antiemetic dexamethasone therapy in chemotherapy-treated cancer patients. Cancer Res Treat. 2016; 48:1429–1437.

30. Santoni M, Conti A, Partelli S, Porta C, Sternberg CN, Procopio G, et al. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Ann Surg Oncol. 2015; 22:2094–2100.